K261-1432 Screening compound: ethyl 2-[(2-{[4-(1,1-dioxo-1,2-dihydro-1lambda~6~,2,4-benzothiadiazin-3-yl)butanoyl]oxy}acetyl)amino]benzoate

K261-1432 Screening compound: ethyl 2-[(2-{[4-(1,1-dioxo-1,2-dihydro-1lambda~6~,2,4-benzothiadiazin-3-yl)butanoyl]oxy}acetyl)amino]benzoate
K261-1432 Screening compound: ethyl 2-[(2-{[4-(1,1-dioxo-1,2-dihydro-1lambda~6~,2,4-benzothiadiazin-3-yl)butanoyl]oxy}acetyl)amino]benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound K261-1432
ethyl 2-[(2-{[4-(1,1-dioxo-1,2-dihydro-1lambda~6~,2,4-benzothiadiazin-3-yl)butanoyl]oxy}acetyl)amino]benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K261-1432

Molecular Formula

C22H23N3O7S (C22 H23 N3 O7 S)

Compound Name

ethyl 2-[(2-{[4-(1,1-dioxo-1,2-dihydro-1lambda~6~,2,4-benzothiadiazin-3-yl)butanoyl]oxy}acetyl)amino]benzoate

IUPAC name

ethyl 2-(2-{[4-(11-dioxo-2H-1lambda624-benzothiadiazin-3-yl)butanoyl]oxy}acetamido)benzoate

SMILES

CCOC(c(cccc1)c1NC(COC(CCCC(N1)=Nc(cccc2)c2S1(=O)=O)=O)=O)=O

InChI

InChI=1S/C22H23N3O7S/c1-2-31-22(28)15-8-3-4-9-16(15)24-20(26)14-32-21(27)13-7-12-19-23-17-10-5-6-11-18(17)33(29,30)25-19/h3-6,8-11H,2,7,12-14H2,1H3,(H,23,25)(H,24,26)

InChI Key

GOEYSDXEQWVSCC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD07655091

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.51

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.959

Distribution Coefficient, logD

1.633

Water Solubility, LogSw

-2.79

Polar Surface Area

114.364

Acid Dissociation Constant (pKa)

7.35

Base Dissociation Constant (pKb)

5.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.30

K261-1432 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with K261-1432 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K261-1432?
Check Price and Availability of K261-1432, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K261-1432 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K261-1432
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K261-1432
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K261-1432 available by request